Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria
- 1 February 2009
- journal article
- research article
- Published by Elsevier BV in International Journal for Parasitology
- Vol. 39 (3), 363-370
- https://doi.org/10.1016/j.ijpara.2008.10.005
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Common Strategies To Prevent and Modulate Experimental Cerebral Malaria in Mouse Strains with Different SusceptibilitiesInfection and Immunity, 2008
- Phagocyte-Derived Reactive Oxygen Species Do Not Influence the Progression of Murine Blood-Stage Malaria InfectionsInfection and Immunity, 2005
- Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway InhibitionInfection and Immunity, 2005
- Effect of kynurenine 3‐hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeysMovement Disorders, 2005
- Role of human brain microvascular endothelial cells during central nervous system infectionThrombosis and Haemostasis, 2005
- Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endotheliumInternational Journal for Parasitology, 2004
- Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsThe Journal of Experimental Medicine, 2002
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Quantification of Local De Novo Synthesis Versus Blood Contributions to Quinolinic Acid Concentrations in Brain and Systemic TissuesJournal of Neurochemistry, 1997
- Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicansJournal of Neuroimmunology, 1994